Rv0696 Mycofactocin system glycosyltransferase

Summary

Product Feature Type Start End Strand Length AA Length is TF
Rv0696 Mycofactocin system glycosyltransferase CDS 795519 796931 + 1 413 470 FALSE

Rv0696 (Mycofactocin system glycosyltransferase) is predicted to be co-regulated in modules bicluster_0363 with residual 0.35 and bicluster_0579 with residual 0.51.

This regulation is possibly mediated by two de-novo identified cis-regulatory motifs in each module with e-values , and for bicluster_0363 and 940.00 and 3,500.00 for bicluster_0579 respectively.

These modules are enriched for following go terms: tetrapyrrole metabolic process, tetrapyrrole biosynthetic process, organonitrogen compound biosynthetic pro..., heterocycle biosynthetic process, IMP biosynthetic process, 'de novo' IMP biosynthetic process, IMP metabolic process, organic cyclic compound biosynthetic pro....

This gene is found to be for growth on cholesterol.

Mutant available?: Yes

Last update: 10/16/2017 - 05:58
BEI Mutant Available BEI Mutant ID BEI MT Number BEI Target ID Order from BEI
Yes NR-15005 MT0723 528
Product (LegacyBRC) Product (RefSeq)
PROBABLE MEMBRANE SUGAR TRANSFERASE membrane sugar transferase
Operon # Operon
466 -
PATRIC Locus Tag Enzyme Name PATRIC Pathways Transcriptomics

PATRIC

Not assigned Not assigned
Locus Tuberculist Genome View

Tuberculist

Quickview
Locus Tag KEGG Pathways

KEGG

not assigned to any KEGG Pathway.
BioCyc Gene Page Cellular Overview Map
Link to STRING STRING Network

STRING

GI Number Protein ID Blast Conserved Domains
15607836 NP_215210.1 Run
GO:0005829

cytosol

cytosol

Details: 
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
GO Category: 
cellular_component
371
Total items in this category:  
No TFOE experiment results were found

Quantitative Proteomics Data

t-test p-value Cholesterol/Glycerol Ratio
0.020000 0.06

How essentiality calculations were done?

The relative representation of each mutant was determined by calculating the fold change (sequence reads/insertion in cholesterol divided by sequence reads/insertion in glycerol) for each gene. Statistical significance was determined by t-test. Each insertion site in each replicate sample was treated as a separate data point. The hyperbola used for defining genes specifically required for growth in cholesterol was defined by the formula, y = 3.8/x+0.7. Genes above this line are annotated as required for growth on cholesterol.

TRIP log2 fold abundance change

reports the log2 abundance fold change of each TFI strain, relative to no induction, in absence or presence of drug, averaged across experimental replicates. Also reported are the accompanying z-scores and two-sided t-test p-values for each TFI strain under each condition. Please refer to Ma et al., 2020, Nature Microbiology for more information.

p-value Untreated:
p-value INH: